Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Wein Matthew received 11,000 Metagenomi Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Wein Matthew (See Remarks) received 11,000 Metagenomi Therapeutics, Inc. shares as an award, leaving 125,549 shares. Filed Apr 3, 2026 (Form 4).
- Awarded
- 11,000 shares
- Holding after
- 125,549 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Award | 11,000 | 125,549 | Direct |
Source
Related
- Metagenomi Therapeutics, Inc.
- Wein Matthew
- Metagenomi Therapeutics, Inc. shareholders
- Form 4 · Wein Matthew · Sep 10, 2026
- Form 4 · Wein Matthew · Jun 10, 2026
- Form 4 · Reid Laurence · Sep 11, 2026
- Form 4 · Irish Jian · Sep 10, 2026
- Form 4 · Wapnick Pamela · Sep 10, 2026
- Schedule 13G · Thomas Brian C. · Sep 10, 2026
- Form 4 · Wapnick Pamela · Jun 10, 2026